Penumbra designs, develops, manufactures, and markets medical devices for the neurovascular and peripheral vascular markets, with a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Its products include the Penumbra System, Penumbra Coil 400, 5MAX ACE, and Neuron System. The company sells its products in North and South America, Europe, Australia, and Asia, primarily to hospitals and healthcare providers through its direct sales organization in the United States, most of Europe, Canada, and Australia, and through distributors in select international markets. Penumbra generates the majority of its revenue in the United States and is a global healthcare company focused on innovative therapies.